An overview of concepts for cancer stem cells

Cell Transplantation

Volumn 20, Issue 1, 2011, Pages 113-120

  Chen, Shih Yin ^a,b   Huang, Yu Chuen ^a,b   Liu, Shih Ping ^b   Tsai, Fuu Jen ^a,c   Shyu, Woei Cherng ^b   Lin, Shinn Zong ^b,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

Author keywords

Adult stem cells; Cancer stem cell (CSC); Self renewal; Tumor initiating cells

Indexed keywords

BRAIN TUMOR; BREAST CANCER; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENESIS; CELL RENEWAL; COLON CANCER; HEMATOPOIETIC SYSTEM; HUMAN; LUNG ADENOCARCINOMA; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

BRAIN; BREAST; COLON; FEMALE; HUMANS; LUNG; MALE; NEOPLASTIC STEM CELLS; OVARY; PANCREAS; PROSTATE;

EID: 79952513882     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X532837     Document Type: Review

References (72)

1. Al-Hajj, M.; Clarke, M. F. Self-renewal and solid tumor stem cells. Oncogene 23(43):7274-7282; 2004.
2. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100(7):3983-3988; 2003.
3. Bannister, L. H. Respiratory system. In: Williams P. L.; Warwick R.; Dyson M.; Bannister L. H., eds. Gray's anatomy. New York: Churchill Livingstone; 1999:1666-1672.
4. Bapat, S. A.; Mali, A. M.; Koppikar, C. B.; Kurrey, N. K. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 65(8):3025-3029; 2005.
5. Bonnet, D.; Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3(7):730-737; 1997.
6. Bonnet, D.; Warren, E. H.; Greenberg, P. D.; Dick, J. E.; Riddell, S. R. CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc. Natl. Acad. Sci. USA 96(15):8639-8644; 1999.
7. Burleson, K. M.; Casey, R. C.; Skubitz, K. M.; Pambuccian, S. E.; Oegema, Jr., T. R.; Skubitz, A. P. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol. Oncol. 93(1):170-181; 2004.
8. Castor, A.; Nilsson, L.; Astrand-Grundström, I.; Buitenhuis, M.; Ramirez, C.; Anderson, K.; Strömbeck, B.; Garwicz, S.; Béká ssy, A. N.; Schmiegelow, K.; Lausen, B.; Hokland, P.; Lehmann, S.; Juliusson, G.; Johansson, B.; Jacobsen, S. E. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat. Med. 11(6):630-637; 2005.
9. Charafe-Jauffret, E.; Ginestier, C.; Iovino, F.; Wicinski, J.; Cervera, N.; Finetti, P.; Hur, M. H.; Diebel, M. E.; Monville, F.; Dutcher, J.; Brown, M.; Viens, P.; Xerri, L.; Bertucci, F.; Stassi, G.; Dontu, G.; Birnbaum, D.; Wicha, M. S. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69(4):1302-1313; 2009.
10. Cheung, A. M.; Wan, T. S.; Leung, J. C.; Chan, L. Y.; Huang, H.; Kwong, Y. L.; Liang, R.; Leung, A. Y. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 21(7):1423-1430; 2007.
11. Chute, J. P.; Muramoto, G. G.; Whitesides, J.; Colvin, M.; Safi, R.; Chao, N. J.; McDonnell, D. P. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 103(31):11707-11712; 2006.
12. Clarke, M. F.; Dick, J. E.; Dirks, P. B.; Eaves, C. J.; Jamieson, C. H.; Jones, D. L.; Visvader, J.; Weissman, I. L.; Wahl, G. M. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 66(19):9339-9344; 2006.
13. Cobaleda, C.; Gutierrez-Cianca, N.; Perez-Losada, J.; Flores, T.; García-Sanz, R.; González, M.; Sánchez- García, I. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood 95(3):1007-1013; 2000.
14. Collins, A. T.; Berry, P. A.; Hyde, C.; Stower, M. J.; Maitland, N. J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65(23):10946-10951; 2005.
15. Corti, S.; Locatelli, F.; Papadimitriou, D.; Donadoni, C.; Salani, S.; Del Bo, R.; Strazzer, S.; Bresolin, N.; Comi, G. P. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 24(4):975-985; 2006.
16. Cox, C. V.; Evely, R. S.; Oakhill, A.; Pamphilon, D. H.; Goulden, N. J.; Blair, A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 104(9):2919-2925; 2004.
17. Craft, N.; Chhor, C.; Tran, C.; Belldegrun, A.; DeKernion, J.; Witte, O. N.; Said, J.; Reiter, R. E.; Sawyers, C. L. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res. 59(19):5030-5036; 1999.
18. Dalerba, P.; Cho, R. W.; Clarke, M. F. Cancer stem cells: Models and concepts. Annu. Rev. Med. 58:267-284; 2007.
19. Dalerba, P.; Dylla, S. J.; Park, I. K.; Liu, R.; Wang, X.; Cho, R. W.; Hoey, T.; Gurney, A.; Huang, E. H.; Simeone, D. M.; Shelton, A. A.; Parmiani, G.; Castelli, C.; Clarke, M. F. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 104(24):10158-10163; 2007.
20. DeMarzo, A. M.; Meeker, A. K.; Epstein, J. I.; Coffey, D. S. Prostate stem cell compartments. Expression of the cell cycle inhibitor p27kip1 in normal, hyperplastic, and neoplastic cells. Am. J. Pathol. 153(3):911-919; 1998.
21. Dick, J. E. Acute myeloid leukemia stem cells. Ann. NY Acad. Sci. 1044:1-5; 2005.
22. Dick, J. E. Breast cancer stem cells revealed. Proc. Natl. Acad. Sci. USA 100(7):3547-3549; 2003.
23. Fang, D.; Nguyen, T. K.; Leishear, K.; Finko, R.; Kulp, A. N.; Hotz, S.; Van Belle, P. A.; Xu, X.; Elder, D. E.; Herlyn, M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65(20):9328-9337; 2005.
24. Fearon, E. R.; Jones, P. A. Progressing toward a molecular description of colorectal cancer development. FASEB J. 6(10):2783-2790; 1992.
25. Fearon, E. R.; Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61(5):759-767; 1990.
26. Feuring-Buske, M.; Frankel, A. E.; Alexander, R. L.; Gerhard, B.; Hogge, D. E. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors. Cancer Res. 62(6):1730-1736; 2002.
27. Ginestier, C.; Hur, M. H.; Charafe-Jauffret, E.; Monville, F.; Dutcher, J.; Brown, M.; Jacquemier, J.; Viens, P.; Kleer, C. G.; Liu, S.; Schott, A.; Hayes, D.; Birnbaum, D.; Wicha, M. S.; Dontu, G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5):555-567; 2007.
28. Gu, G.; Yuan, J.; Wills, M. L.; Kasper, S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 67(10):4807-4815; 2007.
29. Guan, Y.; Gerhard, B.; Hogge, D. E. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 101(8):3142-3149; 2003.
30. Guzman, M. L.; Jordan, C. T. Considerations for targeting malignant stem cells in leukemia. Cancer Control 11(2): 97-104; 2004.
31. Guzman, M. L.; Neering, S. J.; Upchurch, D.; Grimes, B.; Howard, D. S.; Rizzieri, D. A.; Luger, S. M.; Jordan, C. T. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 98(8):2301-2307; 2001.
32. Hamann, P. R.; Hinman, L. M.; Hollander, I.; Beyer, C. F.; Lindh, D.; Holcomb, R.; Hallett, W.; Tsou, H. R.; Upeslacis, J.; Shochat, D.; Mountain, A.; Flowers, D. A.; Bernstein, I. Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Bioconjug. Chem. 13(1): 47-58; 2002.
33. Holyoake, T.; Jiang, X.; Eaves, C.; Eaves, A. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94(6):2056-2064; 1999.
34. Holyoake, T. L.; Jiang, X.; Drummond, M. W.; Eaves, A. C.; Eaves, C. J. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia 16(4):549-558; 2002.
35. Jackson, E. L.; Willis, N.; Mercer, K.; Bronson, R. T.; Crowley, D.; Montoya, R.; Jacks, T.; Tuveson, D. A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15(24):3243-3248; 2001.
36. Jordan, C. T. Unique molecular and cellular features of acute myelogenous leukemia stem cells. Leukemia 16(4): 559-562; 2002.
37. Jordan, C. T.; Guzman, M. L. Mechanisms controlling pathogenesis and survival of leukemic stem cells. Oncogene 23(43):7178-7187; 2004.
38. Jordan, C. T.; Upchurch, D.; Szilvassy, S. J.; Guzman, M. L.; Howard, D. S.; Pettigrew, A. L.; Meyerrose, T.; Rossi, R.; Grimes, B.; Rizzieri, D. A.; Luger, S. M.; Phil lips, G. L. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14:1777-1784; 2000.
39. Kawamoto, H.; Yuasa, T.; Kubota, Y.; Seita, M.; Sasamoto, H.; Shahid, J. M.; Hayashi, T.; Nakahara, H.; Hassan, R.; Iwamuro, M.; Kondo, E.; Nakaji, S.; Tanaka, N.; Kobayashi, N. Characteristics of CD133(+) human colon cancer SW620 cells. Cell Transplant. 19(6):851-864; 2010.
40. Kim, C. F.; Jackson, E. L.; Woolfenden, A. E.; Lawrence, S.; Babar, I.; Vogel, S.; Crowley, D.; Bronson, R. T.; Jacks, T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6):823-835; 2005.
41. Kondo, M.; Wagers, A. J.; Manz, M. G.; Prohaska, S. S.; Scherer, D. C.; Beilhack, G. F.; Shizuru, J. A.; Weissman, I. L. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu. Rev. Immunol. 21:759-806; 2003.
42. Lang, S. H.; Frame, F.; Collins, A. Prostate cancer stem cells. J. Pathol. 217(2):299-306; 2009.
43. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Callgiuri, M. A.; Dick, J. E. A cell initiating human acute leukaemia after transplantation into SCID mice. Nature 367(6464):645-648; 1994.
44. Larson, R. A.; Sievers, E. L.; Stadtmauer, E. A.; Löwenberg, B.; Estey, E. H.; Dombret, H.; Theobald, M.; Voliotis, D.; Bennett, J. M.; Richie, M.; Leopold, L. H.; Berger, M. S.; Sherman, M. L.; Loken, M. R.; van Dongen, J. J.; Bernstein, I. D.; Appelbaum, F. R. Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer 104(7):1442-1452; 2005.
45. Li, C.; Heidt, D. G.; Dalerba, P.; Burant, C. F.; Zhang, L.; Adsay, V.; Wicha, M.; Clarke, M. F.; Simeone, D. M. Identification of pancreatic cancer stem cells. Cancer Res. 67(3):1030-1037; 2007.
46. Liu, A. Y.; Nelson, P. S.; van den Engh, G.; Hood, L. Human prostate epithelial cell-type cDNA libraries and prostate expression patterns. Prostate 50(2):92-103; 2002.
47. Maitland, N. J.; Collins, A. T. Prostate cancer stem cells: A new target for therapy. J. Clin. Oncol. 26(17):2862-2870; 2008.
48. Matsui, W.; Huff, C. A.; Wang, Q.; Malehorn, M. T.; Barber, J.; Tanhehco, Y.; Smith, B. D.; Civin, C. I.; Jones, R. J. Characterization of clonogenic multiple myeloma cells. Blood 103(6):2332-2336; 2004.
49. Mazo, M.; Gavira, J. J.; Abizanda, G.; Moreno, C.; Ecay, M.; Soriano, M.; Aranda, P.; Collantes, M.; Alegría, E.; Merino, J.; Peñuelas, I.; García Verdugo, J. M.; Pelacho, B.; Prósper, F. Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat. Cell Transplant. 19(3):313-328; 2010.
50. Miller, S. J.; Lavker, R. M.; Sun, T. T. Interpreting epithelial cancer biology in the context of stem cells: Tumor properties and therapeutic implications. Biochim. Biophys. Acta 1756(1):25-52; 2005.
51. Nagle, R. B.; Ahmann, F. R.; McDaniel, K. M.; Paquin, M. L.; Clark, V. A.; Celniker, A. Cytokeratin characterisation of human prostatic carcinoma and its derived cell lines. Cancer Res. 47(1):281-286; 1987.
52. Natali, P. G.; Nicotra, M. R.; Sures, I.; Santoro, E.; Bigotti, A.; Ullrich, A. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res. 52(22):6139-6143; 1992.
53. Navarro-Alvarez, N.; Kondo, E.; Kawamoto, H.; Hassan, W.; Yuasa, T.; Kubota, Y.; Seita, M.; Nakahara, H.; Hayashi, T.; Nishikawa, Y.; Hassan, R. A.; Javed, S. M.; Noguchi, H.; Matsumoto, S.; Nakaji, S.; Tanaka, N.; Kobayashi, N.; Soto-Gutierrez, A. Isolation and propagation of a human CD133-negative colon tumor derived cell line with tumorigenic and angiogenic properties. Cell Transplant. 19(6):865-877; 2010.
54. Nelson, H.; Petrelli, N.; Carlin, A.; Couture, J.; Fleshman, J.; Guillem, J.; Miedema, B.; Ota, D.; Sargent, D.; National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J. Natl. Cancer Inst. 93(8):583-596; 2001.
55. O'Brien, C. A.; Pollett, A.; Gallinger, S.; Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106-110; 2007.
56. O'Connell, J. B.; Maggard, M. A.; Ko, C. Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J. Natl. Cancer Inst. 96(19): 1420-1425; 2004.
57. Pardal, R.; Clarke, M. F.; Morrison, S. J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3(12):895-902; 2003.
58. Patrawala, L.; Calhoun, T.; Schneider-Broussard, R.; Li, H.; Bhatia, B.; Tang, S.; Reilly, J. G.; Chandra, D.; Zhou, J.; Claypool, K.; Coghlan, L.; Tang, D. G. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25(12):1696-1708; 2006.
59. Prince, M. E.; Sivanandan, R.; Kaczorowski, A.; Wolf, G. T.; Kaplan, M. J.; Dalerba, P.; Weissman, I. L.; Clarke, M. F.; Ailles, L. E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 104(3):973-978; 2007.
60. Radtke, F.; Clevers, H. Self-renewal and cancer of the gut: Two sides of a coin. Science 307(5717):1904-1909; 2005.
61. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 415(6859):105-111; 2001.
62. Reynolds, B. A.; Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255(5052):1707-1710; 1992.
63. Shizuru, J. A.; Negrin, R. S.; Weissman, I. L. Hematopoietic stem and progenitor cells: Clinical and preclinical regeneration of the hematolymphoid system. Annu. Rev. Med. 56:509-538; 2005.
64. Singh, S. K.; Clarke, I. D.; Terasaki, M.; Bonn, V. E.; Hawkins, C.; Squire, J.; Dirks, P. B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63(18):5821-5828; 2003.
65. Szotek, P. P.; Pieretti-Vanmarcke, R.; Masiakos, P. T.; Dinulescu, D. M.; Connolly, D.; Foster, R.; Dombkowski, D.; Preffer, F.; Maclaughlin, D. T.; Donahoe, P. K. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc. Natl. Acad. Sci. USA 103(30):11154-11159; 2006.
66. Taussig, D. C.; Pearce, D. J.; Simpson, C.; Rohatiner, A. Z.; Lister, T. A.; Kelly, G.; Luongo, J. L.; Danet Desnoyers, G. A.; Bonnet, D. Hematopoietic stem cells express multiple myeloid markers: Implications for the origin and targeted therapy of acute myeloid leukemia. Blood 106(13):4086-4092; 2005.
67. Terpstra, W.; Ploemacher, R. E.; Prins, A.; van Lom, K.; Pouwels, K.; Wognum, A. W.; Wagemaker, G.; Löwenberg, B.; Wielenga, J. J. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood 88(6): 1944-1950; 1996.
68. Van Leenders, G. J.; Schalken, J. A. Stem cell differentiation within the human prostate epithelium: Implications for prostate carcinogenesis. BJU Int. 88(Suppl. 2):35-42; 49-50; 2001.
69. Wang, J. C.; Dick, J. E. Cancer stem cells: Lessons from leukemia. Trends Cell Biol. 15(9):494-501; 2005.
70. Yanagi, S.; Kishimoto, H.; Kawahara, K.; Sasaki, T.; Sasaki, M.; Nishio, M.; Yajima, N.; Hamada, K.; Horie, Y.; Kubo, H.; Whitsett, J. A.; Mak, T. W.; Nakano, T.; Nakazato, M.; Suzuki, A. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J. Clin. Invest. 117(10):2929-2940; 2007.
71. Yang, Y.; Iwanaga, K.; Raso, M. G.; Wislez, M.; Hanna, A. E.; Wieder, E. D.; Molldrem, J. J.; Wistuba, I. I.; Powis, G.; Demayo, F. J.; Kim, C. F.; Kurie, J. M. Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer. PLoS ONE 3(5):e2220; 2008.
72. Zhang, S.; Balch, C.; Chan, M. W.; Lai, H. C.; Matei, D.; Schilder, J. M.; Yan, P. S.; Huang, T. H.; Nephew, K. P. Identification and characterization of ovarian cancer initiating cells from primary human tumors. Cancer Res. 68(11):4311-4320; 2008.